Complex nutrition albumen powder for preventing women's osteosporosis after menopause

Abstract

The invention relates to a compound protein powder for preventing postmenopausal women from osteoporosis. The components and weight percentage thereof are: 55 percent to 80 percent of soybean protein powder; 15 percent to 35 percent of whey powder, 0.2 percent to 0.8 percent of soybean isoflavone, 1 percent to 5 percent of oligosaccharide, 1.2 percent to 2.4 percent of calcium lactate, 0.5 percent to 1 percent of stabilizer and 0.5 percent to 1.5 percent of lecithin. The product of the invention is safe and reliable to eat, which has good effect, innocuity, no side effects and dependence. Furthermore, the invention can protect the health of middle-aged women by eating often, especially for improving the healthy problems caused by lacking of estrogen, so as to improve the life quality and living quality of women. Therefore, the invention can be taken as a protein complementary product to be eaten frequently by women.

Description

technical field [0001] The invention relates to a compound nutritional protein powder, in particular to a compound nutritional protein powder for preventing postmenopausal osteoporosis in women. Background technique [0002] With the increase of our country's aging population, osteoporosis has become another disease that threatens our health after cardiovascular disease and cancer. Investigations show that my country is the country with the largest number of osteoporosis patients in the world at present, with about 90 million patients, accounting for about 7% of the total population. [0003] Osteoporosis is particularly harmful to postmenopausal women. After menopause, the level of estrogen in the body of women drops sharply, the inhibition of osteoclasts is weakened, the osteolysis is accelerated, and the bone formation is weakened, resulting in a large loss of bone calcium, which leads to osteoporosis. In my country, the incidence rate of osteoporosis in 60-69-year-old ...

AI Technical Summary

Problems solved by technology

[0004] Estrogen replacement therapy (HRT) is the main method to prevent osteoporosis in postmenopausal women. A large number of studies have shown that the application of HRT can prevent postmenopausal osteoporosis very well, but HRT will produce its side effects while preventing osteoporosis , such as breast cancer, ovarian cancer, cardiovascular disease and gastrointestinal adverse reactions, as well as some women's psychological concerns, cannot be accepted by all women who lack estrogen